Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
NCT ID: NCT00518050
Last Updated: 2015-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2006-10-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Melanoma Risk-Reduction Among Patients and Family Members
NCT00510302
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
NCT00745862
Adolescent Survivors of Cancer or Similar Illnesses
NCT00579631
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
NCT01356251
Quality of Life in Patients With Nonmelanoma Skin Cancer
NCT00518037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Specific Aim 1- Focus Group
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of:
* Screening, skin self-examination, sun protection, and other cancer preventive practices;
* Cognitive factors (knowledge, awareness, melanoma worry, and perceived risk) related to screening and sun protection practices; and,
* Impact of melanoma on quality of life, family relationships, and economic issues arising from treatment
Focus group
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of:
* Screening, skin self-examination, sun protection, and other cancer preventive practices;
* Cognitive factors (knowledge, awareness, melanoma worry, and perceived risk) related to screening and sun protection practices; and,
* Impact of melanoma on quality of life, family relationships, and economic issues arising from treatment
Specific Aim 2- Survey Study
A separate random sample of melanoma survivors will complete the pilot questionnaire. To enhance completion rates, survey instruments will be developed to be both self-administered and interviewer-administered. The survey will include questions from existing surveys, regarding demographics, sun sensitivity, eye and hair color, color of untanned skin, sun exposure, skin selfexamination, sun protection practices and frequency of sunburns, psychosocial/cognitive factors: skin cancer knowledge, skin awareness, cancer worry, perceived risk of recurrence, cancer risk and screening behaviors, and access to health care and insurance.
Survey
History of sun exposure Medical factors Affect, cognition, and quality of life Behavioral adoption Demographics Phenotypic factors Economic/healthcare factors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus group
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of:
* Screening, skin self-examination, sun protection, and other cancer preventive practices;
* Cognitive factors (knowledge, awareness, melanoma worry, and perceived risk) related to screening and sun protection practices; and,
* Impact of melanoma on quality of life, family relationships, and economic issues arising from treatment
Survey
History of sun exposure Medical factors Affect, cognition, and quality of life Behavioral adoption Demographics Phenotypic factors Economic/healthcare factors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
For the survey group recruitment (Specific Aim 2):
patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 2001-2011• Ability to sign informed consent which indicates the psychosocial, behavioral, epidemiological nature of this study
• Age ≥ or = to 18 years and fluent in the English language
Exclusion Criteria
* Patients with stage IV melanoma
* Patients with nodal or visceral melanoma without a documented primary lesion
* Patients with prior malignancies For the focus group recruitment (Specific Aim 1): (patients treated at MSKCC from 1996-2005) who have a diagnosis \>10 years ago from treatment. For the survey group recruitment (Specific Aim 2): patients treated at MSKCC from 2001-2011)who have a diagnosis \>10 years ago from treatment.
* Patients with a recent diagnosis of melanoma, \<12 months
* Patients who are one year or more post diagnosis and are still receiving treatment for their melanoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Oliveria, ScD, MPH
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan-Kettering Cancer Center 1275 York Avenue
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.